438 related articles for article (PubMed ID: 26515786)
1. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
[TBL] [Abstract][Full Text] [Related]
2. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
[TBL] [Abstract][Full Text] [Related]
3. Preserved central cholinergic functioning to transcranial magnetic stimulation in de novo patients with celiac disease.
Lanza G; Fisicaro F; D'Agate CC; Ferri R; Cantone M; Falzone L; Pennisi G; Bella R; Hadjivassiliou M; Pennisi M
PLoS One; 2021; 16(12):e0261373. PubMed ID: 34914787
[TBL] [Abstract][Full Text] [Related]
4. In vivo functional evaluation of central cholinergic circuits in vascular dementia.
Di Lazzaro V; Pilato F; Dileone M; Profice P; Marra C; Ranieri F; Quaranta D; Gainotti G; Tonali PA
Clin Neurophysiol; 2008 Nov; 119(11):2494-500. PubMed ID: 18829384
[TBL] [Abstract][Full Text] [Related]
5. A review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia.
Nardone R; Golaszewski S; Ladurner G; Tezzon F; Trinka E
Dement Geriatr Cogn Disord; 2011; 32(1):18-25. PubMed ID: 21822020
[TBL] [Abstract][Full Text] [Related]
6. Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation.
Lanza G; Bramanti P; Cantone M; Pennisi M; Pennisi G; Bella R
Behav Neurol; 2017; 2017():1421326. PubMed ID: 28348458
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study.
Nardone R; De Blasi P; Seidl M; Höller Y; Caleri F; Tezzon F; Ladurner G; Golaszewski S; Trinka E
J Neural Transm (Vienna); 2011 Sep; 118(9):1349-58. PubMed ID: 21516477
[TBL] [Abstract][Full Text] [Related]
8. Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body.
Marra C; Quaranta D; Profice P; Pilato F; Capone F; Iodice F; Di Lazzaro V; Gainotti G
Brain Stimul; 2012 Oct; 5(4):533-8. PubMed ID: 22019082
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study.
Pennisi M; Lanza G; Cantone M; Ricceri R; Spampinato C; Pennisi G; Di Lazzaro V; Bella R
Neural Plast; 2016; 2016():8154969. PubMed ID: 27525127
[TBL] [Abstract][Full Text] [Related]
10. Cortical afferent inhibition reflects cognitive impairment in obstructive sleep apnea syndrome: a TMS study.
Nardone R; Bergmann J; Brigo F; Höller Y; Schwenker K; Florea C; Kunz AB; Golaszewski S; Trinka E
Sleep Med; 2016 Aug; 24():51-56. PubMed ID: 27810186
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study.
Nardone R; Bergmann J; Tezzon F; Ladurner G; Golaszewski S
J Neural Transm (Vienna); 2008 May; 115(5):737-43. PubMed ID: 18188496
[TBL] [Abstract][Full Text] [Related]
12. Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy.
Celebi O; Temuçin ÇM; Elibol B; Saka E
Parkinsonism Relat Disord; 2014 Jun; 20(6):632-6. PubMed ID: 24698055
[TBL] [Abstract][Full Text] [Related]
13. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.
Kim HJ; Moon WJ; Han SH
J Alzheimers Dis; 2013; 35(1):129-36. PubMed ID: 23364137
[TBL] [Abstract][Full Text] [Related]
14. Subjective memory impairment and cholinergic transmission: a TMS study.
Nardone R; Höller Y; Bathke AC; Höller P; Lochner P; Tezzon F; Trinka E; Brigo F
J Neural Transm (Vienna); 2015 Jun; 122(6):873-6. PubMed ID: 25504007
[TBL] [Abstract][Full Text] [Related]
15. Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.
Motta C; Di Lorenzo F; Ponzo V; Pellicciari MC; Bonnì S; Picazio S; Mercuri NB; Caltagirone C; Martorana A; Koch G
J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1237-1242. PubMed ID: 30464028
[TBL] [Abstract][Full Text] [Related]
16. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment.
Nardone R; Bergmann J; Christova M; Caleri F; Tezzon F; Ladurner G; Trinka E; Golaszewski S
J Neural Transm (Vienna); 2012 Apr; 119(4):463-71. PubMed ID: 22016008
[TBL] [Abstract][Full Text] [Related]
17. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment.
Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H
PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867
[TBL] [Abstract][Full Text] [Related]
18. Association between cortical thickness and distinct vascular cognitive impairment and dementia in patients with white matter lesions.
Liu Y; Hu A; Chen L; Li B; Zhang M; Xi P; Yang Q; Tang R; Huang Q; He J; Lang Y; Zhang Y
Exp Physiol; 2021 Jul; 106(7):1612-1620. PubMed ID: 33866642
[TBL] [Abstract][Full Text] [Related]
19. Short latency afferent inhibition in Parkinson's disease patients with dementia.
Celebi O; Temuçin CM; Elibol B; Saka E
Mov Disord; 2012 Jul; 27(8):1052-5. PubMed ID: 22605543
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.
Padovani A; Benussi A; Cantoni V; Dell'Era V; Cotelli MS; Caratozzolo S; Turrone R; Rozzini L; Alberici A; Altomare D; Depari A; Flammini A; Frisoni GB; Borroni B
J Alzheimers Dis; 2018; 65(1):221-230. PubMed ID: 30010131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
